Content of the study:
The Insulin Pump Market - France

Available languages

MARKET OVERVIEW

1.1 Insulin pump market overview and definition

The insulin pump is a treatment method for diabetics. It is an an interesting alternative to multi-injection therapy insulin injections, helping to maintain better glycemic control. Mimicking the functioning of a normal pancreas, it is an artificial device that delivers insulin at a variable rate to an insulin-dependent diabetic requiring insulin on a permanent basis.

Theinsulin pump can be implanted (rarely prescribed by physicians) or external (subcutaneous injection) . Operation is straightforward, with in-hospital training and regular follow-up with the diabetologist and pump vendor.

The global insulin market is growing, dominated by a handful of very powerful laboratories offering insulin pens and oral medications. Insulin pump sales constitute one segment of the insulin treatment market.

The insulin pump market segment is also growing, and is set to remain so for years to come, driven by the various innovations proposed by traditional and emerging players. This global market is estimated atUS$5.67 billion in 2022, andshould reach US$9.4 billion in 2028 (at aCAGR of 8.8%). [GrandViewResearch]

Indeed, in 2021, there will now be 537 million diabetics in the world, 3.5 times more than in 2000. Between 2019 and 2021, for example, the number of diabetics rose by 74 million. To date, Asia-Pacific has the highest number of people with diabetes (206 million), but the increase is expected to beparticularly strong in Africa (+134% in 2045 compared with 2021) [DiabetesAtlas]

France is one of Europe's biggest consumers of diabetes treatments, with healthcare expenditure linked to this disease amounting to over 22 billion euros in 2021[DiabetesAtlas]. As a result, the insulin pump market is highly dynamic, and is expected to grow at a CAGR of 6.58% over the period 2023-2028. [Mordor Intelligence]

The market for diabetes treatment is very closely linked to the regulations and healthcare system in place. For example, the French social security system allows insulin pump treatment to be reimbursed, and regularly updates the new pumps that are eligible for reimbursement.

1.2 The global market

The global insulin pump market is estimated at US$*.** billion in ****, and is expected to continue growing over the next few years at a CAGR of *.*%, reaching US$*.* billion in ****.

Insulin pump market size World, **** - ****, in billions of USD Source: GandViewResearch (***) : projection

Global market growth drivers include the rising number ...

1.3 Growth in the French market

The following graph shows the evolution of diabetes-related healthcare expenditure in France. This figure includes all diabetes-related expenses in France. It includes, for example, all the costs of insulin therapy, visits to healthcare professionals and equipment, as well as all the resources devoted to prevention, nutrition and so on. It also ...

DEMAND ANALYSIS

2.1 The profile of diabetes patients

The number of diabetics under care is trending upwards in France, rising from *.* million in **** to * million in ****, an increase of **% in just * years. However, by ****, the number of people in care would have fallen by ***,***, before rising again by ***,*** in ****, to around *.* million.

People treated for diabetes in **** (***) France, **** - ...

2.2 Obesity and overweight as risk factors

Obesity and diabetes are two closely related diseases. In fact, according to the Pasteur Institute in Lille, obesity is the leading risk factor for diabetes, and **% of obese people also suffer from diabetes. The increase in obesity and overweight is the main reason for the sharp rise in the number of ...

2.3 Insulin pump users among diabetics

Of the *,***,*** diabetic patients who were treated in ****, (***).

According to Has-Santé, the population of French patients using external insulin pumps stood at **,*** in ****. This would mean that only *% of diabetics would be using this device. According to lvlmedical, however, *% of diabetics will be using an insulin pump. by way of comparison, ...

MARKET STRUCTURE

3.1 The central role of health insurance and reimbursements

The French Assurance Maladie plays a central role in the insulin pump market, as it does for many drugs, treatments and medical equipment. As diabetes is classified as a long-term condition (***), costs are ***% covered by the French health insurance system, whether for diabetes-related care or for complications: ocular, vascular, renal or ...

3.2 The main players in the diabetes treatments market

The global market for anti-diabetic treatments is not very fragmented, and is dominated by a handful of large international groups. Evaluate Pharma provides annual reports on the global pharmaceutical market, but only the **** report focuses on the anti-diabetic market.

In ****, the top ** groups accounted for over **% of total market value, including ...

3.3 Leading insulin pump manufacturers

The French insulin pump market is highly fragmented and dominated by a handful of industry giants .

Medtronic

Sales of the Medtronic group's Diabetes division have grown steadily in recent years, from $*.** billion in **** to $*.** billion in ****. A world leader in medical technologies, the group has a very strong presence in the ...

OFFER ANALYSIS

4.1 Insulin pump typology

Insulin pumps are medical devices used in the treatment of diabetes (***). Compared with multi-injection therapy, the insulin pump enables patients to maintain a freer, more flexible lifestyle, with greater flexibility in mealtimes, as well as better monitoring of blood glucose levels, and therefore a lower risk of complications.

The insulin pump ...

4.2 Product innovation on the market

Digital technology in diabetes treatment

Manufacturers in the insulin therapy market are increasingly investing in the connected objects segment to meet consumer expectations. For example, Abbott and Sanofi, as well as Medtronic and Novo Nordisk, have signed alliances in **** to advance in the connected pen segment.

In particular, Abbott has launched ...

REGULATIONS

5.1 Supervision of insulin pump therapy

Prescriptions[***]

Insulin pumps are reimbursed by the French national health insurance scheme (***) for type * and type * diabetes which cannot be controlledby insulin therapy using multiple subcutaneous injections of insulin.

The initial prescription for an external insulin pump (***) must be made in an initiating center. This prescription is valid for a maximum ...

POSITIONING THE PLAYERS

To keep reading, buy the full research

What is in this market study?

  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What are the latest trends in this market?
  • What is the positioning of companies in the value chain?
  • How do companies in the market differ from each other?
  • Access company mapping and profiles.
  • Data from several dozen databases

  • This market study is available online and in pdf format (30 p.)
  • Consult an example PDF or online

Our other products

Our other products

Pack 5 études (-15%) - France

378 €

  • 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
  • Conservez -15% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez les conditions du pack et de remboursement des crédits non consommés.

Buy

Method

Method
Data
Analysts 1 sector analyzed
in 40 pages
Method
Control

Analysts

  • Top Universities
  • Expert opinion

Data

  • Databases
  • Press
  • Company reports

Control

  • Continuously updated
  • Permanent watch

Method

  • Synthetic structure
  • Standardized charts

Reviews (1)

Reviews (1)

The Insulin Pump Market - France

Publicado en 11/01/2022 by Amaury Wernert

A very precise and detailed study of this market, driven by the strong growth of this disease in the world


Businesscoot Response:

Hello Amaury, Thank you for your feedback. We are happy to read that the content of the study has fully met your expectations. :)

Customer cases and references

Customer cases and references
La pépite Interview
Linkedin logo

BFM Business

La pépite Interview

Paul-Alexis Kebabtchieff
Linkedin logo

Boston Consulting Group

Paul-Alexis Kebabtchieff

Marie Guibart
Linkedin logo

Kea Partners

Marie Guibart

Elaine, Durand
Linkedin logo

Crédit Agricole, Information & Veille

Elaine, Durand

Philippe Dilasser
Linkedin logo

Initiative & Finance

Philippe Dilasser

Anne Baudry
Linkedin logo

Metro

Anne Baudry

Amaury Wernert
Linkedin logo

Kroll (Duff & Phelps)

Amaury Wernert

Smart Leaders Interview
Linkedin logo

B-Smart

Smart Leaders Interview